ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,949.17
      -0.60%
      US Tech 100
      20,266.80
      -1.09%
      Dow Jones
      43,750.86
      -0.47%
      Brent Oil
      71.805
      -0.56%
      Bitcoin
      87,566.23
      0.25%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Mainz BioMed NV (MYNZ)

      7. Mainz BioMed NV (MYNZ) Financials

      Mainz BioMed NV

      Mainz BioMed NV (MYNZ)

      NASDAQ
      0.2485
      -0.0015
      (-0.60%)
      Closed November 15 4:00PM
      Delayed by 15 minutes
      0.25
      0.0015
      (0.60%)
      After Hours: 7:57PM
      Delayed by 15 minutes

      Mainz BioMed NV Financial Summary

      The current MYNZ market cap is 5.29M. The company's latest EPS is USD and P/E is N/A.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 250k249k181k215k
      Operating Income -6.56M-7.93M-5.64M-6.54M
      Net Income -6.56M-8.25M-6.3M-5.18M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 281k493k577k529k895k
      Operating Income -921k-674k-9.73M-26.18M-26.6M
      Net Income -957k-587k-11.69M-26.39M-26.3M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 19.54M19.31M17.91M15.41M
      Total Liabilities 9.86M14.13M14.46M12.16M
      Total Equity 9.68M5.18M3.45M3.25M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 0673k10.04M20.24M15.41M
      Total Liabilities 03.41M3.68M6.15M12.16M
      Total Equity 0-2.74M6.36M14.1M3.25M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -5.66M-10.78M-17.28M-21.94M
      Investing -1.4M-1.53M-1.64M-1.9M
      Financing 773k6.19M10.76M14.23M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -416k-468k-3.22M-14.77M-21.94M
      Investing N/A -9k1.2M-658k-1.9M
      Financing 423k396k10.61M23.94M14.23M

      Stats and Ratios

      Market Cap 5.29M
      Price to Earnings Ratio N/A
      Price to Sales Ratio 0
      Price to Cash Ratio 0
      Price to Book Ratio 0
      Dividend Yield -

      Share Statistics

      Shares Outstanding 21.17M
      Average Volume (1 week) 12.97M
      Average Volume (1 Month) 4.93M
      52 Week Change -79.84%
      52 Week High 1.79
      52 Week Low 0.1852
      Spread (Intraday) 0 (0.8%)

      Company Info

      Company Name Mainz BioMed NV
      Address keizersgracht 391a
      amsterdam, north holland
      Website https://www.mainzbiomed.com
      Industry testing laboratories (8734)